HALCYGEN PHARMACEUTICALS LIMITED
HGN - Submission of IND Application to US FDA - Dr Roger Aston, CEO
Wednesday, 14 May 2008 5:30pm
Consensus Data
| Broker | EPS (A$) | Sales (A$) | ||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | 2011 | 2009 | 2010 | 2011 | |
| Patersons | -0.05 | 0.03 | 0.00 | 0.61 | 36.71 | 0.00 |
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Audio Duration: 07:09
Dr Roger Aston
Wed, 14 May 2008
5:30pm Australia/Sydney
Select a tab above to display more information
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
ASX code: HGN
Website: http://www.halcygen.com/
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Principal Activities:
The manufacture and development of super generic drugs
Address:
470 Collins Street, Level 10
MELBOURNE
VIC
Phone: (03) 8614 7777
Fax: (03) 9614 7022
Executives & Directors
Dr Roger Aston , Chairman, CEO
The Hon Ron Best , Non Exec. Director
Mr Bruce Mathieson , Non Exec. Director
Mr Ian Scholes , Non Exec. Director
Mr Aaron Finlay , CFO
Ms Lisa Pendlebury , Investor Relations
Mr Aaron Finlay , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
HALCYGEN PHARMACEUTICALS LIMITED (HGN) Events
| Company (Stock Code) | Date/Time | Event |
|
|---|---|---|---|
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Tue, 31 Aug 2010 | Full Year Results |
|
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Thu, 15 Apr 2010 2:00pm |
HalcyGen Completes Recruitment of its US-conducted Phase II Study for SUBA®-Itraconazole: Simone Parkes, Business Development | ![]() |
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Wed, 28 Oct 2009 12:00pm |
Annual General Meeting Stamford Plaza Hotel, 111 Little Collins Street, Melbourne, VIC
|
|
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Tue, 15 Sep 2009 | Full Year Results | |
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Thu, 26 Feb 2009 | Interim Results | |
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Fri, 21 Nov 2008 11:00am 11:00am Australia/Melbourne |
Annual General Meeting Stamford Plaza Hotel, 111 Little Collins St, Melbourne, VIC
|
|
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Wed, 14 May 2008 5:30pm |
HGN - Submission of IND Application to US FDA - Dr Roger Aston, CEO | ![]() |
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Tue, 20 Nov 2007 10:00am |
Annual General Meeting Batman's Hill on Collins, 623 Collins Street Melbourne VIC
|
|
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Fri, 31 Aug 2007 | Full Year Results | |
|
HALCYGEN PHARMACEUTICALS LIMITED
(HGN) |
Thu, 28 Jun 2007 | Full Year Results | |
HALCYGEN PHARMACEUTICALS LIMITED (HGN)
| Preliminary Final Report and Maiden Dividend | Tue, 31 Aug 2010 |
| F10 Financial Results Presentation | Tue, 31 Aug 2010 |
| Singapore Distribution Agreement Signed | Thu, 26 Aug 2010 |
| US Sales of Doryx Update | Wed, 11 Aug 2010 |
| Appendix 3B | Fri, 6 Aug 2010 |
| Senior Management Appointment | Thu, 5 Aug 2010 |
| Director resignation and management update | Thu, 29 Jul 2010 |
| Appendix 3B | Thu, 29 Jul 2010 |
| Amended Final Director`s Interest Notice | Thu, 29 Jul 2010 |
| Final Director`s Interest Notice | Thu, 29 Jul 2010 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.





















